Vanda Pharmaceuticals buy marge
Start price
30.10.17
/
50%
€14.03
Target price
04.11.21
€18.86
Performance (%)
11.22%
End price
05.11.21
€15.60
Summary
This prediction ended on 05.11.21 with a price of €15.60. The prediction had a final performance of 11.22%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vanda Pharmaceuticals | 13.971% | 13.971% | 69.956% | 32.479% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % | 53,31 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % | 93,48 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % | 52,32 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % | 66,74 % |
Comments by marge for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda mit positiven Analystenkommentaren
- Vanda Pharmaceuticals (NASDAQ:VNDA) price target raised to $26 (77% upside) from $21 by Oppenheimer citing more bullish forecasts for Hetlioz (Outperform).
Kursziel geändert auf 18,864
In the thread Trading Vanda Pharmaceuticals
Die von marge gewählte maximale Laufzeit wurde überschritten